Timing Matters: How Premeal Insulin Enhances Postprandial Glucose Control and Myocardial Microvascular Blood Flow in Type 1 Diabetes

Highlight

• Premeal insulin administration lowers postprandial hyperglycaemia significantly in young adults with type 1 diabetes compared to postmeal insulin.
• Premeal insulin leads to a significant increase in myocardial microvascular blood flow, indicating improved myocardial perfusion.
• The study utilized a randomised crossover design, with vascular and metabolic parameters rigorously assessed and blinded outcome assessment.
• No significant changes were observed in myocardial microvascular blood flow in control participants or with postmeal insulin administration.

Study Background

Type 1 diabetes mellitus (T1DM) is characterized by absolute insulin deficiency leading to chronic hyperglycaemia. Postprandial hyperglycaemia contributes to vascular dysfunction and is linked to an increased risk of cardiovascular disease, the leading cause of morbidity and mortality in T1DM. Optimizing insulin timing to better control postprandial glucose excursions has been a clinical goal but its impact on vascular function, specifically myocardial microvascular blood flow (MBF), has been understudied. Understanding whether appropriately timed prandial insulin can improve vascular perfusion could deliver clinically meaningful cardiovascular benefits in this population.

Study Design

This was a randomised, crossover clinical trial involving 18 adults with type 1 diabetes (age 18–35 years, BMI <30 kg/m²) and 18 age-, sex-, and BMI-matched healthy controls. Participants with T1DM underwent two separate protocols in random order: administration of prandial rapid-acting insulin either 15 minutes before or 15 minutes after consuming a standardized meal. Controls ate the same meal without insulin to provide a physiological reference. Key assessments included glucose and insulin levels, myocardial and skeletal muscle microvascular perfusion via ultrasound measures, aortic stiffness, brachial artery endothelial function, and biomarkers related to systemic inflammation and endothelial dysfunction. All measurements were taken at baseline and 2 hours post-meal. The primary endpoint was change in myocardial MBF within each protocol. Outcome assessors were masked to intervention assignment.

Key Findings

Postprandial Glycaemia: The glucose area under the curve (AUC) was significantly higher in the postmeal insulin protocol compared to premeal insulin administration (p=0.015) among participants with T1DM, confirming improved postprandial glucose control with premeal insulin.

Myocardial Microvascular Blood Flow: Premeal insulin resulted in a statistically significant increase in myocardial microvascular flow velocity (p=0.031), which translated into greater myocardial MBF (p=0.044) compared to baseline. This was not observed in the postmeal insulin protocol nor among healthy controls.

Vascular Function and Biomarkers: There were no significant changes in brachial artery endothelial function, aortic stiffness, or systemic inflammatory and endothelial dysfunction biomarkers across the protocols. Vital signs remained stable throughout.

Overall, these data suggest that timely premeal insulin not only optimizes glycaemic control but also exerts a favorable effect on myocardial microvascular perfusion early after meal ingestion in type 1 diabetes.

Expert Commentary

The present study provides compelling evidence that insulin timing before meals is a modifiable factor influencing myocardial microvascular perfusion in type 1 diabetes. This adds a crucial vascular perspective to the well-established metabolic benefits of premeal insulin administration. The randomized crossover design and blinded assessment strengthen the internal validity of the results.

Mechanistically, improved postprandial glucose control may reduce glucotoxicity-induced microvascular dysfunction, improving capillary recruitment and flow velocity. The absence of changes in systemic inflammatory biomarkers suggests that short-term insulin timing influences perfusion through direct vascular or metabolic pathways rather than systemic inflammation modulation.

Despite the insightful findings, several limitations merit consideration. The young, relatively healthy study population limits extrapolation to older individuals or those with advanced diabetes complications. The short-term nature of the protocol precludes conclusions regarding long-term cardiovascular outcomes. Larger, longer-duration studies incorporating clinical endpoints are needed to translate these physiological findings into practice guidelines.

Conclusion

In summary, premeal administration of prandial insulin significantly lowers postprandial glucose excursions and enhances myocardial microvascular blood flow in young adults with type 1 diabetes compared to insulin given after meal initiation. This study underscores the importance of insulin timing as a strategic intervention to improve myocardial microvascular health, potentially reducing cardiovascular risk in this vulnerable population. Future investigations should delineate underlying mechanisms and examine the impact on clinical cardiovascular events.

Funding and Clinical Trial Registration

This study was registered with ClinicalTrials.gov under identifier NCT04730882. Specific funding sources were not detailed in the abstract; refer to the full publication for acknowledgments.

References

Horton WB, Anderson KC, Love KM, Jahn LA, Hartline LM, Patrie JT, Liu J, Solga MD, Awan WJ, Thakur A, Schalk DL, Becker MG, Kuzas CE, Aylor KW, Barrett EJ. Premeal insulin administration lowers postprandial blood glucose and increases myocardial microvascular blood flow in people with type 1 diabetes: a randomised, crossover clinical trial. Diabetologia. 2026 Jul 11. PMID: 42432283.

Additional relevant literature on T1DM, insulin timing, and cardiovascular risk was consulted for context.